COVID-19: Pharmidex Contingency Plan
March 19, 2020

Pharmidex are taking all the necessary steps to ensure the progression of client studies during these difficult time.

COVID-19: Pharmidex Contingency Plan


We are taking all necessary steps to ensure that studies proceed, while preserving the health and safety of staff. Summary of key steps taken at Pharmidex:


- Following the relevant guidelines issued by Public Health England.


- Limiting access to only essential people in our laboratories and cancelling/rescheduling all non-critical visitors. All visitors must confirm COVID-19 status prior to arrival.


- Cancelled all non-essential business travel.


- Closely communicating with suppliers regarding the status of their inventories and their business continuity plans and identifying alternate sources for supplies.


- Implemented strict sanitization practices to prevent cross contamination between staff, including providing our staff with resources and up-to-date information and guidance.


- To prevent the potential spread of the infection amongst employees, staff will declare any potential close contact with infected individuals and follow the relevant health guidelines.


- Our operations team will ensure adequate staffing cover so as not to compromise client studies.


We will keep you updated if the situation changes resulting in any impact on progression of your projects.


Best wishes to everyone during these tough times.

April 24, 2025
Pharmidex is proud to be exhibiting at the 36th BMCS Spring Symposium on Medicinal Chemistry, taking place today at the beautiful Fielder centre in Hatfield! ๐Ÿ›๏ธโœจ We're excited to be part of this key gathering of thought leaders in drug discovery and development, sharing insights, connecting with fellow innovators, and shaping the future of medicinal chemistry. Our very own J anette Dalay Robertson is on-site and would be delighted to meet with attendees. Come say hello! She’s eager to discuss collaboration opportunities and explore how together we can accelerate breakthroughs in drug discovery and preclinical development. ๐Ÿ’ฌ Let’s connect, innovate, and advance science, one molecule at a time.
April 22, 2025
This annual symposium is a key event in the medicinal chemistry calendar, bringing together researchers and industry professionals to discuss cutting-edge advances in drug discovery. Our team will be available to discuss how Pharmidex’s integrated services can support the development of novel therapeutics from early discovery through to candidate selection. ๐Ÿ“ Location: Hatfield, UK ๐Ÿ“… Date: 24th April 2025 ๐Ÿ”— www.pharmidex.com, https://lnkd.in/eZdCsd4M We look forward to engaging with the scientific community and exploring new opportunities for collaboration. Visit our stand or contact [email protected]. See you there!
March 21, 2025
We’re pleased to announce that Janette Dalay Robertson , our Business Development Manager, and Ian Knowles , our Head of Respiratory, will be attending the 2nd SMR Molecular Glues Meeting on Friday, 21st March 2025 at GSK, Stevenage. This event is a fantastic opportunity to engage with fellow scientists, innovators, and industry leaders in the field of molecular glues. Janette and Ian are eager to connect, share insights, and explore new collaborations to advance drug discovery and development. If you’re attending, don’t hesitate to reach out – they would love to meet and discuss how Pharmidex can support your research and development goals! ๐Ÿ”— More about the event: https://lnkd.in/d6yiTkUi
More Posts